Filing Details

Accession Number:
0001181431-13-061537
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-05 15:07:55
Reporting Period:
2013-12-03
Filing Date:
2013-12-05
Accepted Time:
2013-12-05 15:07:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124105 Targacept Inc TRGT Pharmaceutical Preparations (2834) 562020050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219855 James M Barrett 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-03 7,500 $2.71 7,500 No 4 M Direct
Common Stock Acquisiton 2013-12-03 7,500 $4.16 15,000 No 4 M Direct
Common Stock Disposition 2013-12-03 15,000 $5.38 0 No 4 S Direct
Common Stock Disposition 2013-12-05 1,000 $5.13 0 No 4 S Indirect See Note 3
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Indirect See Note 3
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (right to buy) Disposition 2013-12-03 7,500 $0.00 7,500 $2.71
Common Stock Director Stock Option (right to buy) Disposition 2013-12-03 7,500 $0.00 7,500 $4.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-06-17 2019-06-16 No 4 M Direct
0 2013-06-07 2022-06-06 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,563,512 Indirect See Note 4
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.13 to $5.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The Reporting Person is a member of New Enterprise Associates, LLC, which is the sole owner of New Enterprise Associates, Inc. (formerly NEA Development Corp.), the beneficial owner of the shares. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by New Enterprise Associates, Inc. in which the Reporting Person has no pecuniary interest.
  4. The Reporting Person is a general partner of NEA Partners 10, Limited Partnership, which is the sole general partner of New Enterprise Associates 10, Limited Partnership, ("NEA 10") the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA 10 in which the Reporting Person has no pecuniary interest.